中国网浪潮资讯 近日，绍兴企业浙江京新药业股份有限公司投资6000万元合作的上海睿泰生物科技股份有限公司研发的自体眼角膜完成临床试验。据了解，复明后视力可达到0.4，这是目前世界上复明效果最好的人工角膜。

　　CNCAO NEWS Recently,the Autogenous cornea which was developed by Shanghai Ruitai biotechnology Co., Ltd.,and invested 60 million yuan by the Shaoxing Enterprise Zhejiang Jingxin Pharmaceutical Co., Ltd,completed clinical trial.It is understood that after the restoration, the vision can reach 0.4, which is the best artificial cornea in the world.

　　人工眼角膜，是一项革命性的创新，通过提取口腔黏膜细胞研发的自体眼角膜，也是一项世界性难题。

　　Artificial cornea is a revolutionary innovation, is also a worldwide problem by extracting the cornea, which is developed by oral mucosa cell.

　　据介绍，多年来，京新药业每年的研发经费超过2亿元，多项研发产品走在世界前沿。这是新昌县营造“政府推动、企业主动、校企互动”的创新创业良好生态的一个景观。仅2016年，绍兴市新昌县战略性新兴产业产值占比49.6%，新产品产值率50.81%，研发经费支出占GDP的4.45%，技术创新、科技产出、创新环境综合评价均居浙江省前列。

　　According to the introduction, over the years,Jingxin Pharmaceutical Co., Ltd has spent more than two hundred million R&D yuan annually, and many R&D products have been on the cutting edge of the world.This is a good innovative and entrepreneurial landscape of "government promotion, enterprise initiative, school enterprise interaction" in Xinchang county.In 2016 alone, the output value of strategic emerging industries in Shaoxing Xinchang county accounted for 49.6%, and the output value of new products was 50.81%,the R&D expenditure accounted for 4.45% of GDP.The comprehensive evaluation of technological innovation, scientific and technological output, and innovation environment rank the forefront of Zhejiang Province.

　　此外，绍兴新昌县聚焦新兴产业，通过人才引进、海外并购、参股合资等方式，使生物医药、高端装备、航空航天等产业也迅速切入全球产业链高端。

　　In addition, Shaoxing Xinchang country focus on emerging industries, made the biomedical, high-end equipment, aerospace and other industries also quickly cut into the high-end of the  global industrial chain,through the introduction of talent, overseas mergers and acquisitions, joint ventures and this means.

　　（中国网见习作者魏诗盈 综合报道 鲍梦依/译）

来源： 中国网    | 作者：魏诗盈 鲍梦依    | 责编：魏诗盈    审核：张渊

新闻投稿：184042016@qq.com    新闻热线：13157110107